How Is Efficient Pharmaceutical Distribution Measured? The Metrics That Matter to Laboratories and Pharmacies

A pharmaceutical operation can dispatch a large volume of orders and still deliver inconsistent service. Volume describes activity; efficiency requires knowing whether the correct product left in full, arrived within the agreed time frame, maintained its required conditions, and generated enough information to resolve any incident.

Laboratories, distributors, and customers therefore need a shared language of performance indicators. Metrics make it possible to distinguish an occasional delay from a recurring problem, compare periods, and decide where to intervene. They also prevent evaluations from depending solely on perception or on an average that hides differences among channels.

The World Health Organization has proposed straightforward indicators for monitoring the last-mile logistics of medicines and health products. Although each operation must adapt its metrics to the market and contract, the approach reinforces a central idea: availability, service performance, stock levels, expirations, and waste should be assessed together.

Accuracy and Completeness: Was the Requested Order Prepared?

Accuracy compares the order requested with the order prepared or delivered. It should account for the product, presentation, batch when applicable, and quantity. An overall rate may be useful, but it should be paired with the number and type of errors to identify whether the problem originates in the catalog, inventory, picking process, or final verification.

Completeness answers a different question: did the customer receive every confirmed unit? An order may be accurate across the lines shipped and still be incomplete because an item was unavailable. Keeping these indicators separate prevents an organization from labeling a shipment successful when it failed to restore the expected availability.

Recurrence also matters. A presentation associated with repeated shortages or corrections over several cycles deserves a targeted review, even when the operation’s overall average appears favorable.

Time and Reliability: Was the Promise Kept from Start to Finish?

Preparation time measures the period from the moment an order is ready for processing until it can be dispatched. Delivery performance, by contrast, compares the actual arrival against the agreed date or window. Combining these figures makes it impossible to determine whether a delay occurred inside the distribution center, during route planning, or at the customer’s receiving point.

For laboratories and pharmacies, the most useful indicator often combines timeliness and completeness. An order that arrives on time but lacks several critical items does not deliver the same value as a complete shipment. Results should also be analyzed by channel, territory, and priority level because a national chain does not operate under the same conditions as an independent pharmacy or hospital.

The technological transformation of pharmaceutical distribution can accelerate tasks and improve visibility, but it does not replace a shared definition of when each measurement begins and ends. Without that rule, two teams may report different times for the same order.

Availability and Incidents: Does the Service Protect Continuity?

Availability shows whether the agreed products are ready when the customer requests them. It should be interpreted alongside turnover, back orders, and expiration dates. Indiscriminately increasing inventory may raise short-term availability while also increasing the risk of losses from expired products.

Incidents complete the picture. They may include quantity discrepancies, compromised packaging, temperature deviations, rejected deliveries, and returns. Rather than simply counting cases, companies should classify them by cause, severity, product, and point of detection. This makes it possible to prioritize action and determine whether a correction prevents recurrence.

The FEFO system is relevant to this assessment because it organizes outbound inventory according to expiration date. Its effectiveness, however, is not demonstrated simply by stating that the system is in use. It requires data on approaching expiration dates, products that failed to move, and decisions taken to reduce waste.

Agencias J.I. Cohen: Capabilities That Support Reliable Distribution

Agencias J.I. Cohen brings together the capabilities required for reliable pharmaceutical distribution: specialized warehousing, temperature control, FEFO inventory management, quality assurance, and nationwide distribution. The company serves pharmacy chains, independent pharmacies, hospitals, clinics, supermarkets, and public institutions, so its operation must respond to different needs and replenishment cycles.

This structure integrates the operating factors described in this article. Inventory control supports availability and turnover; order preparation and dispatch processes affect accuracy and timeliness; and the preservation of product conditions protects medicine quality throughout the supply chain. Integrating these functions makes it possible to coordinate each stage and turn inventory and demand data into supply decisions.

The new distribution center is part of that evolution. Agencias J.I. Cohen has explained that the project will incorporate robotics to expand installed capacity, accelerate dispatches, and reduce order-preparation errors. Although these remain project objectives, they directly address the criteria that define an efficient operation.

With more than seven decades of experience, Agencias J.I. Cohen has built its reliability on verifiable capabilities and an operation specialized in pharmaceutical products. The combination of compliance, product preservation, coverage, and responsiveness positions it as a strong partner for laboratories, pharmacies, and healthcare facilities in Guatemala.